Anderman Jonathan
SEC CIK 2032625 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CMPX | Compass Therapeutics, Inc. | Gen Counsel, Corp. Sec | 196.0K | $78.0K | — | 4 | 2025-04-07 | 2026-04-29 |
Most active insiders at CMPX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Anderman Jonathan | GC | $47.2K | — |
| 2 | Lerner Neil | CAO | $28.4K | — |
| 3 | Shin Barry | CFO | — | — |
| 4 | Schuetz Thomas J. | CEO, Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-04-30 16:00 | 2026-04-29 | CMPX | Compass Therapeutics, Inc. | Anderman Jonathan | GC | P - Purchase | $1.89 | +25.0K | 196.0K | +15% | +$47.2K |
| 2026-04-29 17:11 | 2026-04-29 | CMPX | Compass Therapeutics, Inc. | Anderman Jonathan | GC | A - Grant | $1.89 | +25.0K | 196.0K | +15% | +$47.2K | |
| D | 2026-01-05 | 2026-01-02 | CMPX | Compass Therapeutics, Inc. | Anderman Jonathan | GC | A - Grant | $5.17 | +150.0K | 171.0K | +714% | +$775.5K |
| 2025-04-08 | 2025-04-07 | CMPX | Compass Therapeutics, Inc. | Anderman Jonathan | Gen Counsel, Corp. Sec | P - Purchase | $1.54 | +20.0K | 21.0K | +2,000% | +$30.8K |
Purchase Sale Sale after option exercise All abbreviations